Lithuania - Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use
Since 2014, Lithuania Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use grew 4.8% year on year. At 45.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was number 27 comparing other countries in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use. Lithuania is overtaken by South Korea, which was ranked number 26 at 46.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Austria at 32.1 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Netherlands lead the ranking with 131.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is an increase of 3.9% compared to 2018. Spain, United Kingdom and Iceland respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +11.3% per year, while Austria was the worst growing country at -14% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 45.90 |
| 2018 | 44.70 |
| 2017 | 43.50 |
| 2016 | 41.20 |
| 2015 | 39.00 |
How does Lithuania rank in Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Netherlands
|
132 | 2019 | +3.9 % | +3.5 % | View data | |
| 2 |
#2
Spain
|
129 | 2019 | +2.8 % | +0.6 % | View data | |
| 26 |
#26
South Korea
|
47 | 2019 | -0.4 % | +0.6 % | View data | |
| 27 |
#27
Lithuania
|
46 | 2019 | +2.7 % | +4.8 % | View data | |
| 28 |
#28
Austria
|
32 | 2019 | -4.5 % | -14.0 % | View data | |